Cargando…
Clinical trials waiver in India-some considerations
Autores principales: | Juneja, Atul, Adhikari, Tulsi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6044129/ https://www.ncbi.nlm.nih.gov/pubmed/30100660 http://dx.doi.org/10.4103/ijp.IJP_540_17 |
Ejemplares similares
-
Letter on: “An analysis of deficiencies in the data of interventional drug trials registered with Clinical Trials Registry – India”
por: Maulik, Mohua, et al.
Publicado: (2020) -
Clinical Trials Registry – India: An overview and new developments
por: Vardhana Rao, M. Vishnu, et al.
Publicado: (2018) -
Clinical Trials Registry – India: A decadal perspective
por: Rao, Mendu Vishnu Vardhana, et al.
Publicado: (2020) -
Emerging trends from COVID-19 research registered in the Clinical Trials Registry - India
por: Rao, M. Vishnu Vardhana, et al.
Publicado: (2021) -
The impact of article processing charge waiver on conducting research in low-income countries
por: Abdul Baki, M-Nasan, et al.
Publicado: (2021)